Aktienanalyse zu Hims & Hers Health Inc (HIMS)HIMSHims & Hers Health Inc

Hims & Hers Health, Inc. operates as a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud-enabled pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of conditions, including primarily those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies. It also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Hims & Hers Health Inc is a good buy right now due to its current price of $30.92, which is below the average analyst price target of $32. Additionally, the stock has shown a positive momentum with a 5-day change of +6.62% and a 20-day change of +12.40%. However, investors should be cautious of the significant net loss of $142 million reported in the latest quarter, which poses a risk to profitability.